Acrivon Therapeutics, Inc. (ACRV) KPIs and segments
ACRVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.43−0.03 (-2.05%)
Close on Nov 17, 2026Market cap $61.28MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Acrivon Therapeutics's business
Coming soon
This tab will track the numbers specific to Acrivon Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?